S
SAB Biotherapeutics (SABS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About SAB Biotherapeutics (SABS)
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of immunotherapeutic polyclonal human antibodies to treat and prevent infectious diseases and immune and autoimmune disorders. Its DiversitAb pl... Read more
- USD3.84
- USD3.84
- USD3.60
- USD6.30
- -10.30%
- 2M
- 74.09k
- 35M
- 2.16
- -38.80%
Stock News
13 minutes ago
People bought cheaper jewelry as holiday gifts. That’s sinking Signet’s stock.
MarketWatch
47 minutes ago
Trump risks repeating Biden’s biggest blunders on the Fed, immigration and China
MarketWatch
52 minutes ago
These two-dozen value stocks are poised to lead the stock market
MarketWatch
58 minutes ago
Oil prices pull back after hitting 4-month highs on Russia sanctions
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
